Principal Investigator

Michael Tyers

Systems Biology and Synthetic Biology

After earning his Ph.D. in Biochemistry at McMaster University, Michael Tyers completed postdoctoral training at the Cold Spring Harbor Laboratory, in New York. He began his career as a teacher in 1992, in the Department of Medical Genetics and Microbiology of the University of Toronto, then held the position of Principal Investigator at the Samuel Lunenfeld Research Institute. In 2007, he became Director of the Scottish Universities Life Sciences Alliance and taught systems biology at The University of Edinburgh.

Upon his return to Canada, he joined the IRIC as Principal Investigator of the Systems Biology and Synthetic Biology Research Unit. Michael Tyers is also a Professor in the Department of Medicine of the Université de Montréal.

Principal Investigator, Systems Biology and Synthetic Biology Research Unit, IRIC

Professor, Department of Medicine, Faculty of Medicine, Université de Montréal

Research unit on systems biology and synthetic biology

Pavillon Marcelle-Coutu, 4306-3

Phone (office)
(514) 343-6111, ext. 6668
Email
md.tyers@umontreal.ca
Apply for a M.Sc. or a Ph.D.

Systems Biology and Synthetic Biology

Michael Tyers and his team use biochemistry, genetics, chemical biology, microscopy, mass spectrometry and informatics to decipher how cellular networks are organized and controlled.

Research topics

Publications

  • June 11, 2020

    Metabolic Regulation of the Epigenome Drives Lethal Infantile Ependymoma.

    Michealraj KA, Kumar SA, Kim LJY, Cavalli FMG, Przelicki D, Wojcik JB, Delaidelli A, Bajic A, Saulnier O, MacLeod G, Vellanki RN, Vladoiu MC, Guilhamon P, Ong W, Lee JJY, Jiang Y, Holgado BL, Rasnitsyn A, Malik AA, Tsai R, Richman CM, Juraschka K, Haapasalo J, Wang EY, De Antonellis P, Suzuki H, Farooq H, Balin P, Kharas K, Van Ommeren R, Sirbu O, Rastan A, Krumholtz SL, Ly M, Ahmadi M, Deblois G, Srikanthan D, Luu B, Loukides J, Wu X, Garzia L, Ramaswamy V, Kanshin E, Sánchez-Osuna M, El-Hamamy I, Coutinho FJ, Prinos P, Singh S, Donovan LK, Daniels C, Schramek D, Tyers M, Weiss S, Stein LD, Lupien M, Wouters BG, Garcia BA, Arrowsmith CH, Sorensen PH, Angers S, Jabado N, Dirks PB, Mack SC, Agnihotri S, Rich JN, Taylor MD
    Cell 2020-06-11 ;181( 6 ):1329-1345.e24.

  • May 14, 2020

    Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response.

    Szewczyk MM, Ishikawa Y, Organ S, Sakai N, Li F, Halabelian L, Ackloo S, Couzens AL, Eram M, Dilworth D, Fukushi H, Harding R, Dela Seña CC, Sugo T, Hayashi K, McLeod D, Zepeda C, Aman A, Sánchez-Osuna M, Bonneil E, Takagi S, Al-Awar R, Tyers M, Richard S, Takizawa M, Gingras AC, Arrowsmith CH, Vedadi M, Brown PJ, Nara H, Barsyte-Lovejoy D
    Nat Commun 2020-05-14 ;11( 1 ):2396.

  • April 15, 2020

    Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.

    Jacques S, van der Sloot AM, C Huard C, Coulombe-Huntington J, Tsao S, Tollis S, Bertomeu T, Culp EJ, Pallant D, Cook MA, Bonneil E, Thibault P, Wright GD, Tyers M
    Genetics 2020-04-15 ;214( 4 ):1103-1120.

  • December 23, 2019

    Robust cullin-RING ligase function is established by a multiplicity of poly-ubiquitylation pathways.

    Hill S, Reichermeier K, Scott DC, Samentar L, Coulombe-Huntington J, Izzi L, Tang X, Ibarra R, Bertomeu T, Moradian A, Sweredoski MJ, Caberoy N, Schulman BA, Sicheri F, Tyers M, Kleiger G
    Elife 2019-12-23 ;8:.

  • August 1, 2019

    Gene Information eXtension (GIX): effortless retrieval of gene product information on any website.

    Knight JDR, Samavarchi-Tehrani P, Tyers M, Gingras AC
    Nat. Methods 2019-08-01 ;16( 8 ):665-666.

  • July 8, 2019

    Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.

    Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella JF, Corneau S, Mayotte N, Girard S, Frechette M, Blouin-Chagnon V, Leveillé K, Boivin I, MacRae T, Krosl J, Thiollier C, Lavallée VP, Kanshin E, Bertomeu T, Coulombe-Huntington J, St-Denis C, Bordeleau ME, Boucher G, Roux PP, Lemieux S, Tyers M, Thibault P, Hébert J, Marinier A, Sauvageau G
    Cancer Cell 2019-07-08 ;36( 1 ):84-99.e8.

  • April 1, 2019

    Proteome-wide, Structure-Based Prediction of Protein-Protein Interactions/New Molecular Interactions Viewer.

    Dong S, Lau V, Song R, Ierullo M, Esteban E, Wu Y, Sivieng T, Nahal H, Gaudinier A, Pasha A, Oughtred R, Dolinski K, Tyers M, Brady SM, Grene R, Usadel B, Provart NJ
    Plant Physiol. 2019-04-01 ;179( 4 ):1893-1907.

  • March 28, 2019

    The p38/HOG stress-activated protein kinase network couples growth to division in Candida albicans.

    Sellam A, Chaillot J, Mallick J, Tebbji F, Richard Albert J, Cook MA, Tyers M
    PLoS Genet. 2019-03-28 ;15( 3 ):e1008052.

  • March 1, 2019

    Drug combinations: a strategy to extend the life of antibiotics in the 21st century.

    Tyers M, Wright GD
    Nat. Rev. Microbiol. 2019-03-01 ;17( 3 ):141-155.

  • January 8, 2019

    The BioGRID interaction database: 2019 update.

    Oughtred R, Stark C, Breitkreutz BJ, Rust J, Boucher L, Chang C, Kolas N, O'Donnell L, Leung G, McAdam R, Zhang F, Dolma S, Willems A, Coulombe-Huntington J, Chatr-Aryamontri A, Dolinski K, Tyers M
    Nucleic Acids Res. 2019-01-08 ;47( D1 ):D529-D541.

  • See all publications

News

  • June 17, 2020

    Race for the discovery of COVID-19 medications: A multidisciplinary project takes shape!

    Génome Québec, in partnership with IRIC, Université de Montréal, Mila – Quebec Artificial Intelligence Institute and McMaster University, is proud to announce funding for a new research project intended to accelerate the discovery of antiviral COVID-19 medications. Spearheaded by professors Michael Tyers (IRIC / Université de Montréal), Yoshua Bengio (Mila / Université de Montréal) and Anne Marinier (IRIC / Université de Montréal), the $1 million project was launched in fast-track mode on June 1, 2020.

  • April 24, 2020

    Michael Tyers’ team and collaborators contribute to COVID-19 research

    We are excited to underscore the commitment made by the team headed by Michael Tyers, Principal Investigator in IRIC’s Systems Biology and Synthetic Biology Research Unit. In collaboration with the teams led by Gerard Wright and Matthew Miller, both of whom are Principal Investigators at McMaster University, the mandate of Michael Tyers’ lab is to identify new therapeutic targets in order to provide better treatment for patients suffering from COVID-19.

  • April 24, 2020

    COVID-19: The IRIC community comes together thanks to IVADO’s support

    IRIC proudly announces the commitment of several of its team in this health crisis, as a result of a spontaneous call for proposals initiated by IVADO, aimed at supporting digital intelligence data science initiatives. The projects retained will be able to rely on funding, scientific support and access to various resources.

  • July 8, 2019

    Treatment of leukemia: IRIC Investigators publish in Cancer Cell

    Researchers at UdeM have discovered a molecular process implicated in the action of anti-leukemia drugs, opening new avenues for the development of effective treatments for this disease.

  • November 13, 2018

    Renewal Michael Tyers’ Canada Research Chair

    Michael Tyers, Principal Investigator at IRIC and Professor at the Faculty of Medicine (Université de Montréal) obtained the renewal of his research chair in Systems and Synthetic Biology.

  • See all news